Termination of transfusion dependence in beta-thalassemia: two-year experience with recombinant human erythropoietin

Pediatr Hematol Oncol. 1997 May-Jun;14(3):285-7. doi: 10.3109/08880019709009500.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Blood Transfusion*
  • Child
  • Erythropoietin / therapeutic use*
  • Female
  • Humans
  • Male
  • Recombinant Proteins / therapeutic use
  • beta-Thalassemia / therapy*

Substances

  • Recombinant Proteins
  • Erythropoietin